12,

13.

14,

1d.

16.

17.

18.

19.

20.

21.

22.

23.

24,

25.

Hollister, L.E., Davis, K.L., Berger, P.A.: Butaclamol hydrochloride in
newly admitted schizophrenics. Psychopharmacol Comm 1:493-500, 1975.

Davis, K.L., Hollister, L.E., Berger, P.A.: Baclophen in schizophrenia.
Lancet 1:1245, 1976,

Hollister, LE., Davis, K.L., Berger, P.A.: Pituitary response to thyrotropin
releasing hormone in depression. Arch Gen Psychiatry 33:1393~-1396, 1976.

Davis, K.L., Berger, P.A., Hollister, L.E.: Tardive dyskinesia and depressive
illness. Psychopharmacol Comm 2:125-131, 1976.

Davis, K.L., Hollister, I.E., Barchas, J.D., Berger, P.A.: Choline in tardive
dyskinesia and Hw tington's disease. Life Sci 19:1507~-1516, 1976.

Davis, K.L., Hollister, L.E., Overall, J., Johnson, A., Train, K.: Physostigmine;
Effects on cognition and affect in normal subjects: Psy chopharm acology 51;
23-27, 1976.

Davis, K.L., Berger, P.A., Hollister, L.E.: Neurotransmitter Functio: Basic

and Clinical Aspects. W.S, Fields (editor). Stratton intercon tinetal,

New York, pp. 247-262, 1977.

Davis, K.L., Hollister, LE., Berger, P.A.: Cholinergic mechanisms in
neurological and psychiatric disorders. In: Neurotransmitters and
Psychiatric Disorders. E. Usdin, D. Hamburg, J. Barchas (eds.),
Oxford University Press, New York, pp. 442-450, 1977.

Hollister, L.E., Davis, K.L, Berger, P.A.: Thyrotropin-releasing hormone:
Central effects in man. In: Neuroregulators and Psychiatric Disorders.
E. Usdin, D. Hamburg, J. Barchas (eds.), Oxford University Press,
New York, pp. 250-258, 1977.

DeFraites, E.F., Davis, K.L., Berger, P.A.: Coexisting tardive dyskinesia and
Parkinsonism; A case report. Biol Psychiatry 12:267-272, 1977.

Davis, K.L,, Estees, F.M., Simonton, S.C., Gonda, T.A.: Effects of Payment in
mode on clinic attendance and rehospitalization. Am J. Psychiatry 134 (5):
567-568, 1977. â€”

Davis, K.L., Berger, P.A., Hollister, L.E.: Deanol for tardive dyskinesia.
Am J. Psychiatry 134:807, 1977,

Davis, K.L.: Psychological effects on nonpsychiatric drugs. In:
Psychopharmacology: From Theory to Practice. J.D. Barchas, P. A.
Berger, R. Ciaranello, G.R. Elliot cas), Oxford University Press, New
York, pp. 469, 1977,

Kendler, K.S., Davis, K.L,; Elevated corticosteroids as possible cause
of abnormal neuroendocrine function in depressive illness. Psychopharmacol
Comm 1:184-194, 1977.

 

50287583